BMJ Ophthalmology,
An adjuvant trial of low-dose dacarbazine and interferon-α-2b in patients with cytogenetic high-risk uveal melanoma showed no…
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes
Overview of attention for article published in British Journal of Ophthalmology, August 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (83rd percentile)
-
High Attention Score compared to outputs of the same age and source (83rd percentile)
Readers on
- mendeley
- 36 Mendeley